Chaperone decline aging refers to the age-related reduction in activity and availability of molecular chaperones that assist protein folding, stabilization, and refolding. Chaperone proteins are essential for maintaining proteome integrity, particularly under stress conditions. With aging, chaperone expression and responsiveness decrease, limiting the cell’s ability to manage misfolded or damaged proteins. This decline contributes to accumulation of protein aggregates and increased cellular stress. Chaperone decline aging affects multiple tissues, especially those with high metabolic or proteostatic demand such as brain and muscle. Reduced chaperone capacity also weakens adaptive stress responses, increasing vulnerability to environmental and metabolic challenges. Understanding chaperone decline aging highlights how loss of protein maintenance capacity contributes to functional deterioration and disease susceptibility during aging.
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom